Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Regeneration: RheumMadness 2022 Axolotl Limbs Scouting Report

Wake Forest School of Medicine Rheumatology Fellowship Program: Khiem Vu, MD; Alyssa Strazanac, MD; John Herion, DO; & Rami Diab, MD  |  Issue: May 2022  |  February 14, 2022

Implications

The management of OA is focused not on regeneration, but on symptoms. This approach can involve topical or oral nonsteroidal anti-inflammatory drugs (NSAIDs), physical therapy or eventually hip or knee joint replacement, if needed. However, this study uncovered a potentially new therapeutic target. Although more secrets certainly remain to be discovered about the underpinnings of human cartilage regeneration and axolotl biology, it’s exciting to ponder a distant—or not too distant—future in which gene therapy for OA is possible with the “injection of key regenerative [microRNA] in a joint, singly or in combination, could potentially enhance endogenous repair and resist degeneration of joint tissues in arthritis of all types, including after traumatic injury or insult.”2

Chances in the Tournament

We acknowledge the stiff competition from our furry, so-called, friends: limping dogs and gouty Dalmatians. Nevertheless, we are quite confident in the axolotl’s chances. Deep inside ourselves, we all have an inner axolotl ready to nourish our joints and help perform activities of daily living, such as walking, jumping and climbing stairs. And its full potential can be harnessed with more research and funding from the U.S. National Institutes of Health.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Last, can’t we all agree that axolotls are a lot more endearing than people, emotionless machines and the other non-smiling, faceless molecules in this year’s tournament?


Khiem Vu, MD, is a first-year rheumatology fellow in the Wake Forest School of Medicine Rheumatology Fellowship Program, Winston-Salem, N.C.

 

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Alyssa Strazanac, MD, is a first-year rheumatology fellow in the Wake Forest School of Medicine Rheumatology Fellowship Program, Winston-Salem, N.C.

John Herion, DO, is a second-year rheumatology fellow in the Wake Forest School of Medicine Rheumatology Fellowship Program, Winston-Salem, N.C.

Rami Diab, MD, is a second-year rheumatology fellow in the Wake Forest School of Medicine Rheumatology Fellowship Program, Winston-Salem, N.C.

References

  1. Deines, T. Mexico City’s endangered axolotl has found fame—is that enough to save it? National Geographic. 2022 Jan 17.
  2. Hsueh MF, Önnerfjord P, Bolognesi MP, et al. Analysis of ‘old’ proteins unmasks dynamic gradient of cartilage turnover in human limbs. Sci Adv. 2019 Oct 9;5(10):eaax3203.

Experience All of RheumMadness

During RheumMadness, rheumatology concepts represent teams that compete against each other in a tournament, much like basketball teams do in the NCAA’s March Madness tournament. In a series for The Rheumatologist, readers will get a chance to read the scouting reports. Check out the reports from each region:

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:anklemicroRNAOsteoarthritisRheumMadness

Related Articles
    Tasha Art; PureSolution / shutterstock.com

    RheumMadness: An Educational Tournament

    July 15, 2021

    RheumMadness is an online collaborative learning experience created to educate trainees, rheumatologists and the wider medical community about recent advances and important concepts in rheumatology. The project is funded by the Rheumatology Research Foundation Clinician Scholar Educator (CSE) Award and modeled after NephMadness, an educational initiative of the American Journal of Kidney Diseases (AJKD) that…

    An Oral Targeted Therapy: RheumMadness 2022 Pim Kinases Scouting Report

    February 8, 2022

    According to research, Pim kinases contribute to the pathogenesis of rheumatoid arthritis (RA) and may have the therapeutic potential for inhibition in patients with RA.

    Conversation: RheumMadness 2022 Reproductive Health Guide Scouting Report

    March 2, 2022

    Rheumatologists play a critical role in the reproductive health of their patients, but only half of rheumatologists currently ask their patients about reproductive health or family planning issues. A new guideline seeks to change that.

    A Unique Breed: RheumMadness 2022 Dalmatian Urate Scouting Report

    February 14, 2022

    Dalmatians have defects in the renal tubular reabsorption of filtered urate and the hepatic conversion of uric acid to allantoin that may provide unique insights into uric acid homeostasis, with implications for the treatment and management of gout.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences